Monroe Terilyn J. 4
4 · Guardant Health, Inc. · Filed Mar 13, 2026
Research Summary
AI-generated summary of this filing
Guardant Health (GH) CPO Terilyn J. Monroe Receives RSU Award
What Happened
- Terilyn J. Monroe, Chief People Officer of Guardant Health (GH), received a grant of 17,040 restricted stock units (RSUs) reported on Form 4 for the 2026-03-11 transaction. The award is reported as an acquisition (derivative) at $0.00 — i.e., compensation stock units, not a cash purchase.
Key Details
- Transaction date: 2026-03-11; Form 4 filed: 2026-03-13 (appears timely).
- Grant: 17,040 RSUs at $0.00 (derivative award; code A).
- Vesting (per footnote F1): 33% vests on April 1, 2027; remaining 67% vests in equal quarterly installments over the following two years.
- Shares owned after transaction: Not specified in this filing.
- Footnotes: F1 = vesting schedule above; F2 = not applicable for RSUs.
Context
- RSUs are a promise to deliver shares upon vesting, so Monroe does not immediately receive tradable shares at grant. Such awards are typically compensation and do not necessarily indicate a personal market buy/sell decision. Taxes and any withholding obligations generally occur at vesting, not at grant.
Insider Transaction Report
Form 4
Monroe Terilyn J.
Chief People Officer
Transactions
- Award
Restricted Stock Units
[F1][F2]2026-03-11+17,040→ 17,040 totalExercise: $0.00→ Common Stock (17,040 underlying)
Footnotes (2)
- [F1]This represents a restricted stock unit award granted on March 11, 2026 that vests over a three-year period. 33% of the shares subject to such award will vest on April 1, 2027 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- [F2]Not applicable for Restricted Stock Units.
Signature
/s/ John G. Saia, as attorney-in-fact for Terilyn J. Monroe|2026-03-13